enow.com Web Search

Search results

1. Results from the WOW.Com Content Network

2. Lutetium (177Lu) vipivotide tetraxetan - Wikipedia

   en.wikipedia.org/wiki/Lutetium_(177Lu)_vipivot...

   Lutetium (177 Lu) vipivotide tetraxetan, sold under the brand name Pluvicto, is a radiopharmaceutical medication used for the treatment of prostate-specific membrane antigen (PSMA)-positive metastatic castration-resistant prostate cancer (mCRPC). [5] [6] Lutetium (177 Lu) vipivotide tetraxetan is a targeted radioligand therapy. [6] [8]

3. Prostvac - Wikipedia

   en.wikipedia.org/wiki/Prostvac

   PROSTVAC is being developed in partnership with the National Cancer Institute under a formal Cooperative Research and Development Agreement and has been the subject of multiple ongoing and completed clinical studies, including the global Phase 3 PROSPECT study underway in patients with asymptomatic or minimally symptomatic metastatic prostate cancer (mCRPC). [2]

4. New prostate cancer treatments lead way at Logansport ... - AOL

   www.aol.com/news/prostate-cancer-treatments-lead...

   Sep. 27—Logansport Memorial Hospital is home to modern prostate cancer treatments that are rarely seen in the United States. The treatments, MRI Fusion Biopsy and High Intensity Focused ...

5. STAMPEDE (clinical trial) - Wikipedia

   en.wikipedia.org/wiki/STAMPEDE_(clinical_trial)

   Systemic Therapy in Advancing or Metastatic Prostate Cancer: Evaluation of Drug Efficacy (STAMPEDE) is a clinical trial investigating treatments for high risk or terminal prostate cancer. Recruitment started in 2005 and ended in 2022; as of January 2020, over 10,000 participants had joined the trial.

6. What You Need to Know About Prostate Cancer Treatments - AOL

   www.aol.com/lifestyle/know-prostate-cancer...

   Doctors recommend different treatments depending on the cancer case. From active surveillance to surgery and targeted therapies, here's what the options are. What You Need to Know About Prostate ...

7. Androgen deprivation therapy - Wikipedia

   en.wikipedia.org/wiki/Androgen_deprivation_therapy

   Androgen deprivation therapy (ADT), also called androgen ablation therapy or androgen suppression therapy, is an antihormone therapy whose main use is in treating prostate cancer. Prostate cancer cells usually require androgen hormones, such as testosterone, to grow. ADT reduces the levels of androgen hormones, with drugs or surgery, to prevent ...